Terms: = Ovarian cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4
33 results:
1. Synthesis and Antiproliferative Activity of Steroidal Diaryl Ethers.
Kovács É; Ali H; Minorics R; Traj P; Resch V; Paragi G; Bruszel B; Zupkó I; Mernyák E
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770863
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of cytotoxic and apoptotic effects of disodium pentaborate decahydrate on ovarian cancer cells and assessment of gene profiling.
Gunel NS; Yildirim N; Ozates NP; Oktay LM; Bagca BG; Sogutlu F; Ozsaran A; Korkmaz M; Biray Avci C
Med Oncol; 2022 Oct; 40(1):8. PubMed ID: 36308567
[TBL] [Abstract] [Full Text] [Related]
3. Anti-Proliferative Acyl Phenols and Arylnonanoids from the Fruit Rind of Myristica malabarica lam.
Bauri AK; Du Y; Brodie PJ; Foro S; Kingston DGI
Chem Biodivers; 2022 Dec; 19(12):e202200343. PubMed ID: 36263966
[TBL] [Abstract] [Full Text] [Related]
4. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or ovarian cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract] [Full Text] [Related]
5. Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer.
Madariaga A; Garg S; Bruce JP; Thiryayi S; Mandilaras V; Rath P; Oza AM; Dhani NC; Cescon DW; Lee YC; Chen E; Wang L; Clarke B; Lheureux S
Gynecol Oncol; 2020 Nov; 159(2):539-545. PubMed ID: 32912664
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological analysis of clinically occult extrapulmonary lymphangioleiomyomatosis in intra-pelvic and para-aortic lymph nodes associated with pelvic malignant tumors: A study of nine patients.
Uehara K; Kawakami F; Hirose T; Morita H; Kudo E; Yasuda M; Märkl B; Zen Y; Itoh T; Imai Y
Pathol Int; 2019 Jan; 69(1):29-36. PubMed ID: 30688413
[TBL] [Abstract] [Full Text] [Related]
7. Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers.
Wang M; Fan W; Ye M; Tian C; Zhao L; Wang J; Han W; Yang W; Gu C; Li M; Zhang Z; Wang Y; Zhang H; Meng Y
Sci Rep; 2018 Jun; 8(1):8990. PubMed ID: 29895933
[TBL] [Abstract] [Full Text] [Related]
8. Screening organometallic thiophene containing thiosemicarbazone ruthenium (II/III) complexes as potential anti-tumour agents.
Tavsan Z; Yaman PK; Subasi E; Kayali HA
J Biol Inorg Chem; 2018 May; 23(3):425-435. PubMed ID: 29569084
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.
Komura N; Mabuchi S; Yokoi E; Kozasa K; Kuroda H; Sasano T; Matsumoto Y; Kimura T
Int J Clin Oncol; 2018 Feb; 23(1):104-113. PubMed ID: 28951992
[TBL] [Abstract] [Full Text] [Related]
10. miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma.
Wang Y; Zhang X; Tang W; Lin Z; Xu L; Dong R; Li Y; Li J; Zhang Z; Li X; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Differ; 2017 Dec; 24(12):2089-2100. PubMed ID: 28800130
[TBL] [Abstract] [Full Text] [Related]
11. CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis.
Glasgow CG; Pacheco-Rodriguez G; Steagall WK; Haughey ME; Julien-Williams PA; Stylianou MP; Gochuico BR; Moss J
Chest; 2018 Feb; 153(2):339-348. PubMed ID: 28576630
[TBL] [Abstract] [Full Text] [Related]
12. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.
Tedaldi G; Tebaldi M; Zampiga V; Danesi R; Arcangeli V; Ravegnani M; Cangini I; Pirini F; Petracci E; Rocca A; Falcini F; Amadori D; Calistri D
Oncotarget; 2017 Jul; 8(29):47064-47075. PubMed ID: 28423363
[TBL] [Abstract] [Full Text] [Related]
13. Sweet Potato Peels and cancer Prevention.
Oluyori AP; Shaw AK; Olatunji GA; Rastogi P; Meena S; Datta D; Arora A; Reddy S; Puli S
Nutr Cancer; 2016; 68(8):1330-1337. PubMed ID: 27673552
[TBL] [Abstract] [Full Text] [Related]
14. MARCKSL1 exhibits anti-angiogenic effects through suppression of VEGFR-2-dependent Akt/PDK-1/mTOR phosphorylation.
Kim BR; Lee SH; Park MS; Seo SH; Park YM; Kwon YJ; Rho SB
Oncol Rep; 2016 Feb; 35(2):1041-8. PubMed ID: 26555156
[TBL] [Abstract] [Full Text] [Related]
15. Malignant presentation of uterine lymphangioleiomyomatosis.
Szpurek D; Szubert S; Zielinski P; Frankowski A; Sajdak S; Moszynski R
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):603-7. PubMed ID: 26522119
[TBL] [Abstract] [Full Text] [Related]
16. Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
Zhao J; Zhao D; Poage GM; Mazumdar A; Zhang Y; Hill JL; Hartman ZC; Savage MI; Mills GB; Brown PH
J Clin Invest; 2015 Jul; 125(7):2707-20. PubMed ID: 26075823
[TBL] [Abstract] [Full Text] [Related]
17. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
[TBL] [Abstract] [Full Text] [Related]
18. Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death.
Yang CS; Matsuura K; Huang NJ; Robeson AC; Huang B; Zhang L; Kornbluth S
Oncogene; 2015 Jun; 34(25):3264-72. PubMed ID: 25151963
[TBL] [Abstract] [Full Text] [Related]
19. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
[TBL] [Abstract] [Full Text] [Related]
20. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.
Tanwar PS; Mohapatra G; Chiang S; Engler DA; Zhang L; Kaneko-Tarui T; Ohguchi Y; Birrer MJ; Teixeira JM
Carcinogenesis; 2014 Mar; 35(3):546-53. PubMed ID: 24170201
[TBL] [Abstract] [Full Text] [Related]
[Next]
